E. Dupont

发表

Clinical trial designs for rare diseases: Studies developed and discussed by the International Rare Cancers Initiative

J. Blay, M. Sydes, A. Benson, 2015, European journal of cancer.

Accurate staging of women with breast cancer

D. Reintgen, C. Cox, E. Dupont, 2002, Journal of surgical oncology.

ignificance of Sentinel Lymph Node icrometastases in Human Breast Cancer

H. E. Cox, J. Kiluk, A. Riker, 2008 .

Completion axillary lymph node dissection minimizes the likelihood of false negatives for patients with invasive breast carcinoma and cytokeratin positive only sentinel lymph nodes.

D. Reintgen, A. Cantor, C. Cox, 2002, American journal of surgery.

Survival Outcomes in Node-Negative Breast Cancer Patients Evaluated With Complete Axillary Node Dissection Versus Sentinel Lymph Node Biopsy

Quan P. Ly, S. Nicosia, M. Meyers, 2006, Annals of Surgical Oncology.

Clinical considerations in breast cancer sentinel lymph node mapping: A moffitt review

C. Cox, E. Dupont, J. Jakub, 2004, Breast cancer.

Benign Mechanical Transport of Breast Epithelial Cells to Sentinel Lymph Nodes

S. Nicosia, A. Cantor, C. Muro-Cacho, 2004, The American journal of surgical pathology.

The role of sentinel lymph node biopsy in women undergoing prophylactic mastectomy.

C. Cox, C. Salud, E. Dupont, 2000, American journal of surgery.

Learning curves and breast cancer lymphatic mapping: institutional volume index.

D. Reintgen, A. Cantor, S. Shivers, 2001, The Journal of surgical research.

The clinical relevance of positive sentinel nodes only versus positive nonsentinel lymph nodes in breast cancer patients.

A. Cantor, C. Cox, E. Dupont, 2003, American journal of surgery.

Making Use of Comparable Health Data to Improve Quality of Care and Outcomes in Diabetes: The EUBIROD Review of Diabetes Registries and Data Sources in Europe

S. de Lusignan, R. Ádány, Inbar Zucker, 2021, Frontiers in Clinical Diabetes and Healthcare.

Do Cytokeratin-Positive-Only Sentinel Lymph Nodes Warrant Complete Axillary Lymph Node Dissection in Patients with Invasive Breast Cancer?

A. Cantor, N. Ku, C. Cox, 2000, The American surgeon.

Radioactive Seed Localization Breast Biopsy and Lumpectomy: Can Specimen Radiographs Be Eliminated?

P. Venugopal, M. Szabunio, C. Berman, 2003, Annals of Surgical Oncology.

Use of reoperative sentinel lymph node biopsy in breast cancer patients.

M. Meyers, J. Kiluk, C. Cox, 2008, Journal of the American College of Surgeons.

Potential of overuse of the inferior vena cava filter.

M. Kerstein, E. Dupont, T. Matsumoto, 1993, Surgery, gynecology & obstetrics.

Problems with the Use of Breast Conservation Therapy for Breast Cancer in a Patient with Neurofibromatosis Type 1: A Case Report

H. Greenberg, C. Cox, E. Dupont, 2008, The breast journal.

Omission of Radiation in Conservative Treatment for Breast Cancer: Opportunity for De-escalation of Care.

A. Chagpar, E. Levine, D. Ollila, 2022, The Journal of surgical research.

Cytokeratin staining for intraoperative evaluation of sentinel lymph nodes in patients with invasive lobular carcinoma.

S. Nicosia, A. Hakam, C. Cox, 2004, American journal of surgery.

Pregnancy‐Associated Breast Cancer Patients Can Safely Undergo Lymphatic Mapping

M. Meyers, J. Kiluk, C. Berman, 2008, The breast journal.

Does Breast Cancer Subtype Impact Margin Status in Patients Undergoing Partial Mastectomy?

A. Chagpar, E. Levine, S. Lum, 2022, The American surgeon.

The effects of postinjection massage on the sensitivity of lymphatic mapping in breast cancer.

G. Lyman, D. Reintgen, C. Berman, 2001, Journal of the American College of Surgeons.

Comment on Rahusen et al.

C. Cox, A. Riker, E. Dupont, 2004, The breast journal.

Novel techniques in sentinel lymph node mapping and localization of nonpalpable breast lesions: The moffit experience

C. Cox, E. Dupont, J. Jakub, 2004, Annals of Surgical Oncology.

se of Reoperative Sentinel Lymph ode Biopsy in Breast Cancer Patients

H. E. Cox, M. Meyers, J. Kiluk, 2008 .

The Role of Lymphoscintigraphy in the Management of the Patient With Breast Cancer

M. Ross, D. Reintgen, S. Shivers, 2001, Annals of Surgical Oncology.

Heparin-Induced Thrombocytopenia

V. Gahtan, J. Mills, E. Dupont, 1999 .

Breast Cancer in Patients with Prior Augmentation: Presentation, Stage, and Lymphatic Mapping

D. Reintgen, A. Cantor, C. Cox, 2004, Plastic and reconstructive surgery.

Are we choosing wisely? Drivers of preoperative MRI use in breast cancer patients.

A. Chagpar, E. Levine, D. Ollila, 2021, American journal of surgery.

Accuracy of intraoperative imprint cytology for sentinel lymph node evaluation in the treatment of breast carcinoma

S. Nicosia, A. Cantor, A. Hakam, 2004, Cancer.

Utility of Internal Mammary Lymph Node Removal When Noted by Intraoperative Gamma Probe Detection

D. Reintgen, N. Ku, C. Cox, 2001, Annals of Surgical Oncology.

Clinical relevance of internal mammary node mapping as a guide to radiation therapy.

D. Reintgen, N. Ku, C. Cox, 2001, American journal of surgery.

Age and Body Mass Index May Increase the Chance of Failure in Sentinel Lymph Node Biopsy for Women with Breast Cancer

D. Reintgen, A. Cantor, C. Cox, 2002, The breast journal.

Significance of sentinel lymph node micrometastases in human breast cancer.

D. Boulware, J. Kiluk, C. Cox, 2008, Journal of the American College of Surgeons.

An update of sentinel lymph node mapping in patients with ductal carcinoma in situ.

A. Cantor, C. Cox, E. Dupont, 2005, American journal of surgery.

Local recurrence in lumpectomy patients after imprint cytology margin evaluation.

S. Nicosia, A. Cantor, H. Greenberg, 2004, American journal of surgery.

Importance of Lymphatic Mapping in Ductal Carcinoma in Situ (DCIS): Why Map DCIS?

D. Reintgen, R. Gray, C. Cox, 2001, The American surgeon.

Sentinel Node Biopsy Before Neoadjuvant Chemotherapy for Determining Axillary Status and Treatment Prognosis in Locally Advanced Breast Cancer

Charles E. Cox, M. Meyers, C. Cox, 2004, Annals of Surgical Oncology.

Recurrent Pneumothorax in a Patient With Rheumatoid Arthritis

M. Flannery, E. Dupont, P. Wallach, 1994 .

Effect of Lymphatic Mapping on Diagnosis and Treatment of Patients With T1a, T1b Favorable Breast Cancer

D. Reintgen, A. Cantor, C. Cox, 2003, Annals of surgery.

Resection of Cavity Shave Margins in Stage 0–III Breast Cancer Patients Undergoing Breast Conserving Surgery

A. Chagpar, E. Levine, A. Berger, 2019, Annals of surgery.

InterAACT: An international multicenter open label randomized phase II advanced anal cancer trial comparing cisplatin (CDDP) plus 5-fluorouracil (5-FU) versus carboplatin (CBDCA) plus weekly paclitaxel (PTX) in patients with inoperable locally recurrent (ILR) or metastatic disease.

J. Welch, A. Benson, D. Cunningham, 2015 .

Impact of Cavity Shave Margins on Margin Status in Patients with Pure Ductal Carcinoma in Situ.

E. Levine, A. Berger, T. Tsangaris, 2020, Journal of the American College of Surgeons.

Abstract P4-14-01: Incidence rate of nipple areolar complex ischemia after nipple sparing mastectomy. Analysis of the American Society of Breast Surgeons Nipple Sparing Mastectomy Registry.

P. Beitsch, S. Feldman, G. Unzeitig, 2012 .